Molson Coors (TAP) Q4 2024 Earnings Transcript

Molson Coors posted full-year underlying EPS growth of 9.8% and underlying free cash flow above $1.2 billion, while returning $1 billion to shareholders via $369 million in dividends and $643 million in buybacks. 2025 guidance calls for low-single-digit constant-currency revenue growth, mid-single-digit pretax income growth, high-single-digit EPS growth, and over $1.3 billion in free cash flow, though it includes a 1.9 million hectoliter headwind from the Pabst and Labatt contract exits. The company also raised its quarterly dividend 6.8% to $0.47 and expanded its U.S. beverage push through Fever-Tree and continued premiumization initiatives.

Analysis

TAP.A’s setup is more interesting than the headline EPS beat: the core earnings algorithm is increasingly being funded by mix, tax, and buybacks rather than clean unit growth. That matters because the market will likely treat 2025 as a “quality of earnings” year—if pricing/mix holds while the contract-brewing drag rolls off, margins can continue to expand even with flat-to-down industry volumes. The first half is the key window where reported growth will look weakest, but that is also when the market is most likely to over-discount the 1.9M hL volume headwind before the margin benefit shows up.

The bigger second-order signal is that management is using capital allocation to re-rate the business profile. Accelerated repurchases plus a higher dividend imply a tighter float and a more defensive equity story, which should support downside even if top-line execution is choppy. The risk is that the market starts to separate reported revenue from economic revenue once it adjusts for mix and non-core exits; if investors do that, TAP.A may struggle to command a durable multiple expansion unless U.S. brand share re-acceleration becomes visible by the summer sell-in cycle.

Fever-Tree and ZOA are strategically smart but near-term financially dilutive in optics: they add revenue complexity, integration noise, and some one-time spend while the core U.S. beer franchise is still digesting shelf resets and the contract-brewing roll-off. The contrarian view is that this is not a classic beer volume story anymore; it is a cash compounder with optionality in premium/non-alc, and the market may be underestimating how much incremental margin Peroni onshoring and lower freight can create over the next 12-24 months. The main catalyst path is simple: if Q2/Q3 industry data looks merely stable while cost savings flow through, the stock can re-rate on FCF durability rather than volume growth.

Key Decisions for Investors

• Long TAP.A common equity into the first-half volume trough, with a 6-9 month horizon; target a rerating on margin durability and buyback support, but trim if U.S. depletion data fails to stabilize by early summer.
• Buy TAP.A Jan-2026 calls or call spreads to express upside from a cleaner second-half compare and buyback acceleration; this is a better risk/reward than outright stock if near-term reported revenue remains noisy.
• Pair long TAP.A vs short a more volume-sensitive beverage/consumer name with less capital return support over the next 3-6 months; TAP.A has a clearer path to EPS resilience if the category stays soft.
• Use any post-earnings or Q1 weakness to accumulate TAP.A, but only if the stock de-risks on contract-brewing fears rather than on a deterioration in core brand share; the former is transient, the latter would invalidate the thesis.
• Avoid chasing before Q2 data: the best entry is likely after the market has fully priced the first-half headwind, since the upside catalyst is improving comparables plus margin realization, not immediate volume growth.